![]() |
市場調查報告書
商品編碼
1642609
全球腸內營養配方市場:成長、未來展望與競爭分析(2024-2032 年)Enteral Feeding Formulas Market - Growth, Future Prospects and Competitive Analysis, 2024 - 2032 |
腸內營養市場包括當口服攝取不足、無法攝取或不安全時透過消化道輸送給患者的各種營養解決方案。這種營養支持方法用於各種醫療保健環境,包括醫院、長期照護機構和家庭護理。腸內營養是臨床營養的重要組成部分,特別適用於慢性疾病患者、手術患者以及營養不良患者。這些腸內營養配方市場的發展受到全球慢性病盛行率上升、配方改善和老年人口成長的推動。預測期內,即 2024-2032 年,腸內營養製劑市場預計將以 7.2% 的複合年增長率成長。
腸內營養配方市場推動因素
慢性病和營養不良發生率上升
癌症、糖尿病和神經系統疾病等慢性疾病的發生率不斷上升,導致患者難以維持足夠的口服攝取量,這是腸內營養製劑市場發展的主要驅動力。這些配方提供的強化營養有助於控制疾病症狀,支持康復並改善患者的整體生活品質。醫院和長期照護機構擴大採用腸內營養作為治療營養不良和疾病相關體重減輕的標準治療方法,進一步推動了對這些產品的需求。
餵食配方和設備的技術進步
腸內營養產品配方和輸送方面的重大技術進步正在擴大其用途和效率。針對特定疾病(如腎衰竭或肺部疾病)患者的獨特營養需求而開發的特定疾病配方,改善了患者的治療效果和營養治療的依從性。營養輸送系統的技術創新,例如能夠實現精確和安全營養輸送的可編程泵,也促進了市場的成長。這些技術進步提高了餵食配方的適口性、吸收性和有效性,從而被各種醫療保健和家庭護理環境廣泛採用。
世界人口老化
全球老年人口不斷增長,更容易患慢性疾病和吞嚥困難,大大推動了腸內營養產品的需求。老年患者通常需要長期營養管理來維持健康並控制與老化相關的生理變化。腸內營養由於使用方便、可在家中進行而成為老年護理的首選,從而支持了該領域市場的持續增長。
制約腸內營養製劑市場的因素
腸內營養相關併發症
儘管腸內營養製劑有許多好處,但其市場卻因管飼相關併發症而受到嚴重限制。管子移位、感染以及腹瀉和便秘等胃腸道併發症等問題可能會阻礙腸內營養的使用。這些併發症需要仔細監測和管理,從而增加了整體醫療保健成本以及臨床醫生和護理人員的負擔。吸入性和由此引發的肺炎的風險也會帶來嚴重的健康風險,尤其是對於老年和重症患者。這項課題影響了醫療保健提供者的腸內營養採用率,他們必須平衡腸內營養的好處和潛在的副作用。管理這些風險的複雜性,再加上需要對護理人員和醫療保健專業人員進行管飼技術的專門培訓,在一定程度上限制了市場的成長潛力。
按產品細分市場
腸內營養製劑市場依產品細分為標準製劑、特定疾病製劑、元素製劑、半元素製劑及其他製劑。針對特定疾病的配方藥物預計將呈現最高的複合年增長率(CAGR),因為它們針對性地治療腎臟疾病、呼吸系統疾病和糖尿病等特定臨床狀況。這些配方旨在滿足這些疾病的特定營養需求和限制,改善患者的治療效果和依從性。同時,標準配方預計將在市場上創造最高的收入。這些配方廣泛用於一般用途,為沒有特定飲食限製或特殊營養需求的患者提供均衡的營養。標準化配方是從醫院到家庭護理等各種醫療環境中腸內營養的基本組成部分,並且已成為腸內營養產業的主力。這些產品的廣泛使用以及腸內營養作為常規臨床護理一部分的日益被接受,為該領域帶來了可觀的收入。
按階段劃分市場
在腸內營養製劑市場中,按階段細分包括成人患者和兒科患者。預計兒科領域將實現最高的複合年增長率,因為在早期發育階段迫切需要適當的營養,以及影響口服攝入的兒童疾病和病症(如發育遲緩、腦性麻痺和囊性纖維化)的發病率不斷上升。兒科配方奶粉是專門為滿足兒童的營養需求而設計的,考慮了兒童的生長需求和代謝率。相較之下,由於大量成年患者需要腸內營養,成人市場佔了最高收入。其中包括患有慢性疾病的老年患者、手術後復健患者、殘疾成年人和接受安寧療護的患者。全球老齡化人口不斷增長以及需要長期營養管理的慢性病的盛行推動了成人市場在銷售中的主導地位,從而確保了對成人專用腸內營養製劑的持續需求。
腸內營養配方市場的區域細分
根據腸內營養製劑市場的地理趨勢,北美目前在收入方面處於領先地位,這得益於先進的醫療基礎設施、高昂的醫療支出以及需要臨床營養解決方案的慢性病患病率的不斷上升。此外,該地區嚴格的監管標準和對腸內營養益處的高度認識繼續主導著市場。同時,亞太地區預計在 2024 年至 2032 年期間的複合年增長率 (CAGR) 最高。這種快速增長的動力是人口老化不斷增長,尤其是在日本和中國等國家,以及醫療支出的增加和醫療基礎設施的改善。這些地區醫院的擴張和需要營養管理的疾病的盛行率增加也是加速市場成長的關鍵因素。此外,政府改善病患治療效果的措施和家庭醫療保健服務的日益普及,增加了亞太地區對腸內營養解決方案的需求,使其成為全球快速擴張的市場。
腸內營養製劑市場的競爭趨勢
腸內營養製劑市場的競爭格局包括Abbott Laboratories、B. Braun Melsungen AG、Baxter International、Danone S.A.、Fresenius Kabi、Functional Formularies、Hormel Health Labs、Kate Farms、Medtrition、Meiji Holdings、Nestle、NutriMedical、Real Food Blends、Vegenat Healthcare、Victus等主要參與者。這些公司透過持續創新和策略舉措來幫助塑造市場動態。2022年,Nestle、Abbott Laboratories等主要參與者憑藉多元化的產品組合和強大的全球分銷網絡實現了強勁的收入。從 2024 年到 2032 年,這些主要參與者預計將專注於擴大其地理覆蓋範圍並增強其產品供應,以滿足不同患者群體的特定營養需求。隨著企業尋求擴大實力並進入新興市場,策略併購預計將變得更加普遍。此外,預計還將增加對研發的投資,重點開發針對各種醫療狀況的更專業、更針對疾病的配方。此外,為了滿足消費者對更清潔、更透明的成分錶的需求,有機和非基因改造配方的開發預計將獲得推動。此外,與醫療保健提供者和醫療組織的合作將加強先進營養解決方案的採用和實施,幫助公司在要求創新和法規遵循的市場中保持競爭力。這些策略將使腸內營養市場領導者保持優勢,同時透過改善患者治療效果和擴大全球影響力來推動市場成長。
The enteral feeding formulas market encompasses a range of nutritional solutions administered to patients via the gastrointestinal tract when oral intake is inadequate, impossible, or unsafe. This method of feeding is used across various healthcare settings including hospitals, long-term care facilities, and home care. Enteral feeding is a vital component of clinical nutrition, especially for patients suffering from chronic diseases, those undergoing surgery, or individuals with malnutrition issues. The market for these formulas is driven by the rising prevalence of chronic diseases, advancements in formula compositions, and the increasing global elderly population. The enteral feeding formulas market is expected to grow at a CAGR of 7.2% during the forecast period of 2024 to 2032.
Drivers of the Enteral Feeding Formulas Market
Rising Incidence of Chronic Diseases and Malnutrition
The increasing prevalence of chronic diseases such as cancer, diabetes, and neurological disorders where patients often experience difficulty in maintaining adequate oral intake is a primary driver for the enteral feeding formulas market. The enhanced nutrition provided by these formulas helps manage disease symptoms, supports recovery, and improves the overall quality of life for patients. Hospitals and long-term care facilities are increasingly adopting enteral nutrition as a standard care practice for managing malnutrition and disease-related wasting, further propelling the demand for these products.
Technological Advancements in Feeding Formulas and Equipment
Significant technological advancements in the formulation and delivery of enteral feeding products have expanded their use and efficiency. The development of disease-specific formulas, which cater to the unique nutritional needs of patients with specific conditions like renal failure or pulmonary disorders, has enhanced patient outcomes and compliance with nutritional therapies. Innovations in feeding delivery systems, such as programmable pumps that ensure precise and safe feeding, have also contributed to market growth. These technological enhancements improve the palatability, absorption, and efficacy of feeding formulas, increasing their adoption across various medical and home care settings.
Aging Global Population
The global increase in the elderly population, who are more prone to chronic conditions and dysphagia (difficulty in swallowing), significantly drives the demand for enteral feeding formulas. Elderly patients often require long-term nutritional management to maintain their health and manage age-related physiological changes. The ease of use and the ability to administer these formulas at home have made enteral nutrition a preferred choice for geriatric care, supporting sustained growth in this segment of the market.
Restraint of the Enteral Feeding Formulas Market
Complications Associated with Enteral Feeding
Despite the benefits, the enteral feeding formulas market faces significant restraints due to the complications associated with tube feeding. Issues such as tube dislodgment, infections, and gastrointestinal complications like diarrhea and constipation can deter the use of enteral feeding. These complications require careful monitoring and management, adding to the overall healthcare costs and burden on providers and caregivers. The risk of aspiration and resultant pneumonia also poses a serious health risk, particularly in elderly and severely ill patients. This challenge impacts the adoption rates of enteral feeding among healthcare providers who must balance the benefits of enteral nutrition with the potential for adverse effects. The complexity of managing these risks, coupled with the need for specialized training for caregivers and healthcare professionals in tube feeding techniques, somewhat limits the market's growth potential.
Market Segmentation by Product
The enteral feeding formulas market is segmented by product into standard formulas, disease-specific formulas, elemental formulas, semi-elemental formulas, and other formulas. Disease-specific formulas are projected to exhibit the highest Compound Annual Growth Rate (CAGR) due to their targeted approach in managing specific clinical conditions such as renal disease, respiratory disease, or diabetes. These formulas are designed to meet the unique nutritional requirements and restrictions of these conditions, enhancing patient outcomes and compliance. On the other hand, standard formulas are anticipated to generate the highest revenue within the market. These formulas are broadly used due to their general application in providing balanced nutrition for patients without specific dietary restrictions or specialized nutritional needs. Standard formulas are a fundamental part of enteral nutrition across various healthcare settings, from hospitals to home care, making them a staple product in the enteral feeding industry. Their widespread use and the growing acceptance of enteral nutrition as a part of routine clinical care drive substantial revenues in this segment.
Market Segmentation by Stage
In the enteral feeding formulas market, segmentation by stage includes adults and pediatric patients. The pediatric segment is expected to experience the highest CAGR owing to the critical need for adequate nutrition in early development stages and the rising incidence of pediatric diseases and disorders that impair oral intake, such as failure to thrive, cerebral palsy, and cystic fibrosis. Pediatric formulas are specially designed to meet the nutritional needs of children, considering their growth requirements and metabolic rates. In contrast, the adult segment accounts for the highest revenue due to the larger volume of adult patients requiring enteral nutrition. This includes elderly patients with chronic illnesses or those undergoing recovery from surgery, as well as adults with disabilities or those receiving palliative care. The adult segment's dominance in revenue is supported by the increasing aging population globally and the prevalence of chronic diseases that necessitate long-term nutritional management, ensuring sustained demand for adult-specific enteral feeding formulas.
Geographic Segment in the Enteral Feeding Formulas Market
Within the enteral feeding formulas market, geographic trends reveal that North America currently leads in terms of revenue, bolstered by advanced healthcare infrastructure, high healthcare spending, and a growing prevalence of chronic diseases that require clinical nutrition solutions. Additionally, the region's stringent regulatory standards and high awareness about the benefits of enteral nutrition sustain its market dominance. Meanwhile, Asia-Pacific is expected to exhibit the highest Compound Annual Growth Rate (CAGR) from 2024 to 2032. This surge is driven by the increasing elderly population, particularly in countries like Japan and China, alongside rising healthcare expenditures and improving healthcare infrastructure. The expansion of hospitals and the increasing prevalence of diseases requiring nutritional management in these regions are also crucial factors accelerating market growth. Furthermore, government initiatives aiming to improve patient outcomes and the growing adoption of home healthcare services are amplifying the demand for enteral feeding solutions in Asia-Pacific, making it a rapidly expanding market within the global landscape.
Competitive Trends in the Enteral Feeding Formulas Market
The competitive landscape in the enteral feeding formulas market features prominent players such as Abbott Laboratories, B. Braun Melsungen AG, Baxter International, Danone S.A., Fresenius Kabi, Functional Formularies, Hormel Health Labs, Kate Farms, Medtrition, Meiji Holdings, Nestle, NutriMedical, Real Food Blends, Vegenat Healthcare, and Victus. These companies have been instrumental in shaping the market dynamics through continuous innovation and strategic initiatives. In 2022, leading companies like Nestle and Abbott Laboratories reported robust revenues driven by their diversified product portfolios and strong global distribution networks. From 2024 to 2032, these key players are expected to focus on expanding their geographic presence and enhancing product offerings to meet the specific nutritional needs of a diverse patient population. Strategic mergers and acquisitions are anticipated to be prevalent as companies aim to broaden their capabilities and access emerging markets. Furthermore, investment in research and development is expected to increase, with a focus on creating more specialized and disease-specific formulas that cater to a range of medical conditions. The development of organic and non-GMO formulas is also anticipated to gain traction, responding to consumer demand for cleaner and more transparent ingredient lists. Additionally, collaborations with healthcare providers and institutions are likely to enhance the reach and implementation of advanced nutritional solutions, ensuring these companies maintain their competitive edge in a market driven by both innovation and regulatory compliance. Through these strategies, the top companies in the enteral feeding formulas market are set to continue their dominance while fostering market growth through enhanced patient outcomes and expanded global reach.
Historical & Forecast Period
This study report represents an analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.
The current report comprises quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends & technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
Research Methodology
The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. The key data points that enable the estimation of Enteral Feeding Formulas market are as follows:
Research and development budgets of manufacturers and government spending
Revenues of key companies in the market segment
Number of end users & consumption volume, price, and value.
Geographical revenues generated by countries considered in the report
Micro and macro environment factors that are currently influencing the Enteral Feeding Formulas market and their expected impact during the forecast period.
Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top-down and bottom-up approach for validation of market estimation assures logical, methodical, and mathematical consistency of the quantitative data.